The Molecular Pathogenesis of Osteosarcoma: A Review
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60%–70%, with no significant improvements in prognosis since the advent of multiagent chemothe...
Main Authors: | Matthew L. Broadhead, Jonathan C. M. Clark, Damian E. Myers, Crispin R. Dass, Peter F. M. Choong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2011/959248 |
Similar Items
-
Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Matthew L. Broadhead, et al.
Published: (2012-01-01) -
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Vijay Chandolu, et al.
Published: (2012-01-01) -
Applying advanced imaging techniques to a murine model of orthotopic osteosarcoma
by: Matthew Lawrence Broadhead, et al.
Published: (2015-08-01) -
The role of LKB1 in the pathogenesis of osteosarcoma
by: Duhamel, L. A. E.
Published: (2011) -
Comparative Aspects of Osteosarcoma Pathogenesis in Humans and Dogs
by: Timothy M. Fan, et al.
Published: (2015-08-01)